Detalhe da pesquisa
1.
Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma.
Gastroenterology
; 159(6): 2203-2220.e14, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32814112
2.
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice.
Cancer Immunol Immunother
; 67(2): 247-259, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29067496
3.
Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy.
Mol Imaging Biol
; 23(6): 941-951, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143379
4.
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers.
Clin Cancer Res
; 26(9): 2188-2202, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31996389
5.
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors.
Clin Cancer Res
; 25(15): 4735-4748, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085720
6.
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1).
Mol Cancer Ther
; 17(1): 243-253, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054985
7.
SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.
Cancer Res
; 65(12): 5358-64, 2005 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15958584
8.
Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase.
Cancer Res
; 64(11): 3958-65, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15173008
9.
Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.
J Med Chem
; 48(4): 1107-31, 2005 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-15715478